Jane Huang

Jane Huang, MD is an Adjunct Clinical Associate Professor at Stanford University in the Department of Medicine - Oncology. She is a board-certified physician in Hematology, Medical Oncology, and Internal Medicine, with a clinical focus on Medical Oncology and Thoracic Oncology for metastatic cancer care.

• Board Certification: American Board of Internal Medicine (Hematology, Medical Oncology, Internal Medicine)
• Fellowship: Stanford University Hematology and Oncology (2004)
• Residency/Internship: Stanford University Internal Medicine (1999-2001)
• Medical Education: University of Washington School of Medicine (1998)

Her research spans ERBB2 (HER2) mutations in non-small cell lung cancer and advance care planning (ACP) for metastatic cancer patients. Recent work explores trastuzumab-based regimens' efficacy for ERBB2-mutant lung cancer, resistance mechanisms, and machine learning models to improve ACP documentation. She also co-authored a 2003 systematic review on low-carbohydrate diets' safety and weight management outcomes.

Analysis of her publications shows trends in oncology care delivery, molecularly targeted therapies, and clinical decision-making. Her ACP study (2022) demonstrated a 35% increase in documentation rates through computer-predicted risk stratification and lay coach interventions.